Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Kim, Kyung Hee ^a   Maldonado, Fabien ^b   Ryu, Jay H ^b   Eiken, Patrick W ^b   Hartman, Thomas E ^b   Bartholmai, Brian J ^b   Decker, Paul A ^b   Yi, Eunhee S ^b  

^a Chungnam National University   (South Korea)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ELASTIN; EOSIN; HEMATOXYLIN; IRON;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPLANT; FEMALE; FIBROSING ALVEOLITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON STORAGE; LUNG ALVEOLUS; LUNG BIOPSY; LUNG FUNCTION; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PULMONARY HYPERTENSION; SCORING SYSTEM; STAINING; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; BIOPSY; CAPILLARY; DOPPLER ECHOCARDIOGRAPHY; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; VASCULARIZATION; VITAL CAPACITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CAPILLARIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; IRON; LOGISTIC MODELS; MALE; MIDDLE AGED; PULMONARY ALVEOLI; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE; VITAL CAPACITY;

EID: 77954637782     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-37     Document Type: Article

References (29)

1. American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias This joint statement of the American thoracic society (ATS), and the European respiratory society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS executive committee, June 2001. Am J Respir Crit Care Med 2002, 165(2):277-304. American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias.
2. Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU. Fibrotic idiopathic interstitial pneumonia: The prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003, 168(5):531-537. 10.1164/rccm.200210-1245OC, 12791580.
3. Nathan SD, Noble PW, Tuder RM. Idiopathic pulmonary fibrosis and pulmonary hypertension: Connecting the dots. Am J Respir Crit Care Med 2007, 175(9):875-880. 10.1164/rccm.200608-1153CC, 17255562.
4. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006, 129(3):746-752. 10.1378/chest.129.3.746, 16537877.
5. King TE, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model. Am J Respir Crit Care Med 2001, 164(7):1171-1181.
6. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005, 128(4):2393-2399. 10.1378/chest.128.4.2393, 16236900.
7. Patel NM, Lederer DJ, Borczuk AC, Kawut SM. Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 2007, 132(3):998-1006. 10.1378/chest.06-3087, 17873194.
8. Lederer DJ, Caplan-Shaw CE, O'Shea MK, Wilt JS, Basner RC, Bartels MN, Sonett JR, Arcasoy SM, Kawut SM. Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis. Am J Transplant 2006, 6(2):398-403. 10.1111/j.1600-6143.2005.01205.x, 16426327.
9. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008, 31(6):1357-1367. 10.1183/09031936.00171307, 18515559.
10. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981, 123(6):659-664.
11. Desai SR, Hansell DM, Walker A, MacDonald SL, Chabat F, Wells AU. Quantification of emphysema: A composite physiologic index derived from ct estimation of disease extent. Eur Radiol 2007, 17(4):911-918. 10.1007/s00330-006-0369-0, 16941093.
12. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998, 157(4 Pt 1):1301-1315.
13. Havlik DM, Massie LW, Williams WL, Crooks LA. Pulmonary capillary hemangiomatosis-like foci. An autopsy study of 8 cases. Am J Clin Pathol 2000, 113(5):655-662. 10.1309/9R7N-19BP-P5QJ-U8E7, 10800397.
14. Hanzlick R, Delaney K. Pulmonary hemosiderin in deceased infants: Baseline data for further study of infant mortality. Am J Forensic Med Pathol 2000, 21(4):319-322. 10.1097/00000433-200012000-00004, 11111789.
15. Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R, Lynch JP, Ardehali A, Goldin J. High-resolution chest ct findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007, 132(3):773-779. 10.1378/chest.07-0116, 2093962, 17573485.
16. Colombat M, Mal H, Groussard O, Capron F, Thabut G, Jebrak G, Brugiere O, Dauriat G, Castier Y, Leseche G, et al. Pulmonary vascular lesions in end-stage idiopathic pulmonary fibrosis: Histopathologic study on lung explant specimens and correlations with pulmonary hemodynamics. Hum Pathol 2007, 38(1):60-65. 10.1016/j.humpath.2006.06.007, 16949908.
17. Nathan SD, Shlobin OA, Ahmad S, Urbanek S, Barnett SD. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007, 131(3):657-663. 10.1378/chest.06-2485, 17356077.
18. Travis WD, Matsui K, Moss J, Ferrans VJ. Idiopathic nonspecific interstitial pneumonia: Prognostic significance of cellular and fibrosing patterns: Survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000, 24(1):19-33. 10.1097/00000478-200001000-00003, 10632484.
19. Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, Endo M, Sasano H, Kondo T, Nukiwa T. Heterogeneous increase in cd34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2004, 169(11):1203-1208. 10.1164/rccm.200308-1111OC, 14754760.
20. Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, Veeraraghavan S, Bishop AE, Romanska HM, Pantelidis P, et al. Interstitial vascularity in fibrosing alveolitis. Am J Respir Crit Care Med 2003, 167(3):438-443. 10.1164/rccm.200202-135OC, 12406847.
21. Magro CM, Waldman WJ, Knight DA, Allen JN, Nadasdy T, Frambach GE, Ross P, Marsh CB. Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies. Hum Immunol 2006, 67(4-5):284-297. 10.1016/j.humimm.2006.02.026, 16720208.
22. Keane MP, Arenberg DA, Lynch JP, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, et al. The cxc chemokines, il-8 and ip-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997, 159(3):1437-1443.
23. Boussat S, Eddahibi S, Coste A, Fataccioli V, Gouge M, Housset B, Adnot S, Maitre B. Expression and regulation of vascular endothelial growth factor in human pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000, 279(2):L371-378.
24. Turner-Warwick M. Precapillary systemic-pulmonary anastomoses. Thorax 1963, 18:225-237. 10.1136/thx.18.3.225, 1018768, 14064617.
25. Keane MP. Angiogenesis and pulmonary fibrosis: Feast or famine?. Am J Respir Crit Care Med 2004, 170(3):207-209. 10.1164/rccm.2405007, 15280169.
26. Voelkel NF, Douglas IS, Nicolls M. Angiogenesis in chronic lung disease. Chest 2007, 131(3):874-879. 10.1378/chest.06-2453, 17356107.
27. Strieter RM, Gomperts BN, Keane MP. The role of cxc chemokines in pulmonary fibrosis. J Clin Invest 2007, 117(3):549-556. 10.1172/JCI30562, 1804376, 17332882.
28. Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, Schwarz MI, Cool CD, Worthen GS. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: A role in aberrant angiogenesis. Am J Respir Crit Care Med 2004, 170(3):242-251. 10.1164/rccm.200308-1151OC, 15117744.
29. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003, 167(5):735-740. 10.1164/rccm.200210-1130OC, 12480614.